Loan Loss Reserves / Non-Performing Loans (Annual)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$15.00M
Net Income	$-197.53M
Cost of Goods Sold	--
Gross Profit	$15.00M
Operating Expenses	$222.69M
Operating Income	$-207.69M
Non-Operating Income/Expense	$11.98M
Pre-Tax Income	$-195.71M
Normalized Pre-Tax Income	$-195.71M
Income after Taxes	$-197.53M
Income from Continuous Operations	$-197.53M
Consolidated Net Income/Loss	$-197.53M
Normalized Income after Taxes	$-197.53M
EBIT	$-207.69M
EBITDA	$-205.62M
Weighted-Average Shares Outstanding (Basic)	135.72M
Weighted-Average Shares Outstanding (Diluted)	135.72M
Earnings per Share (EPS) (Basic)	$-1.46
Earnings per Share (EPS) (Diluted)	$-1.46
Balance Sheet Financials
Current Assets	$367.88M
Property, Plant, and Equipment	$0.81M
Long-Term Assets	$319.62M
Total Assets	$687.50M
Current Liabilities	$42.94M
Long-Term Debt	$110.09M
Long-Term Liabilities	$117.70M
Total Liabilities	$160.63M
Common Equity	$526.86M
Tangible Shareholders Equity	$526.86M
Shareholders Equity	$526.86M
Common Shares Outstanding	149.23M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-193.82M
Cash Flow from Investing Activities	$-418.53M
Cash Flow from Financial Activities	$291.53M
Beginning Cash	$383.22M
End Cash	$61.95M
Increase/Decrease in Cash	$-321.27M
Stock-Based Compensation	$30.96M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	8.57
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.17
Debt to Equity Ratio	0.21
Gross Margin	100.00%
Operating Margin	-1384.61%
EBIT Margin	-1384.61%
EBITDA Margin	-1370.77%
Pre-Tax Profit Margin	-1304.75%
Profit Margin	-1316.88%
Free Cash Flow	$-194.19M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.02
Inventory Turnover	--
Receiveable Turnover	0.28
Days Sales in Receivables	1311.98
Return on Equity	-37.49%
Return on Tangible Equity	-37.49%
Return on Assets	-28.73%
Return on Investments	-31.01%
Book Value Per Share	$3.53
Free Cash Flow per Share	$-1.43
Operating Cash Flow per Share	$-1.43

Data from Zacks Investment Research, Inc.